Moving forward: a treatment overview from the 12th World AIDS Conference.
Agosto
M
M
National Minority AIDS Council, Washington, DC.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D002219:Carbamates; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005663:Furans; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006297:Health Services Accessibility; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D061466:Lopinavir; D010078:Oxazines / Q000627:therapeutic use*; D010347:Patient Care Planning; D011744:Pyrimidinones / Q000627:therapeutic use*; D012074:Remission Induction; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D013557:Switzerland; D014779:Virus Replication / Q000187:drug effects; D000099227:Abacavir
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D002219:Carbamates; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D004791:Enzyme Inhibitors; D005663:Furans; D017320:HIV Protease Inhibitors; D006918:Hydroxyurea; D061466:Lopinavir; D010078:Oxazines; D011744:Pyrimidinones; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir; C098320:efavirenz